CXCL2 and acute myeloid leukemia: Furthermore, the anti-angiogenic cytokine Cxcl2 (also known as MIP-2α or chemokine gro-β; downstream of TNF; Tessier et al., 1997) was significantly more expressed in endosteal AML cells (Figures 3L and 3M).